Clorox Company (CLX) Stock Forecast, Price Target & Predictions
CLX Stock Forecast
Clorox Company stock forecast is as follows: an average price target of $146.67 (represents a -11.79% downside from CLX’s last price of $166.27) and a rating consensus of 'Hold', based on 20 wall street analysts offering a 1-year stock forecast.
CLX Price Target
The average price target for Clorox Company (CLX) is $146.67 based on 1-year price targets from 20 Wall Street analysts in the past 3 months, with a price target range of $185.00 to $122.00. This represents a potential -11.79% downside from CLX's last price of $166.27.
CLX Analyst Ratings
According to 20 Wall Street analysts, Clorox Company's rating consensus is 'Hold'. The analyst rating breakdown for CLX stock is 0 'Strong Buy' (0.00%), 7 'Buy' (35.00%), 11 'Hold' (55.00%), 2 'Sell' (10.00%), and 0 'Strong Sell' (0.00%).
Clorox Company Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 19, 2024 | Lauren Lieberman | Barclays | $122.00 | $136.31 | -10.50% | -26.63% |
| May 02, 2024 | Chris Carey | Wells Fargo | $135.00 | $139.63 | -3.32% | -18.81% |
| Mar 26, 2024 | Kaumil Gajrawala | Jefferies | $145.00 | $150.52 | -3.67% | -12.79% |
| Jan 30, 2024 | Nik Modi | RBC Capital | $138.00 | $145.97 | -5.46% | -17.00% |
| Oct 05, 2023 | Olivia Tong | Raymond James | $185.00 | $124.69 | 48.37% | 11.26% |
| Sep 08, 2023 | Ken Goldman | J.P. Morgan | $153.00 | $155.10 | -1.35% | -7.98% |
| Feb 03, 2023 | - | Morgan Stanley | $145.00 | $141.00 | 2.84% | -12.79% |
| Feb 03, 2023 | - | Raymond James | $165.00 | $141.00 | 17.02% | -0.76% |
| Feb 01, 2023 | - | Jefferies | $145.00 | $143.32 | 1.17% | -12.79% |
| Jan 03, 2023 | - | Wells Fargo | $135.00 | $140.39 | -3.84% | -18.81% |
The latest Clorox Company stock forecast, released on Jul 19, 2024 by Lauren Lieberman from Barclays, set a price target of $122.00, which represents a -10.50% decrease from the stock price at the time of the forecast ($136.31), and a -26.63% decrease from CLX last price ($166.27).
Clorox Company Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 5 |
| Avg Price Target | - | $122.00 | $145.00 |
| Last Closing Price | $166.27 | $166.27 | $166.27 |
| Upside/Downside | -100.00% | -26.63% | -12.79% |
In the current month, the average price target of Clorox Company stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Clorox Company's last price of $166.27. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 28, 2024 | Citigroup | Neutral | Neutral | Hold |
| Jul 22, 2024 | Cowen & Co. | Sell | Buy | Initialise |
| Jul 22, 2024 | Cowen & Co. | - | Sell | Initialise |
| Jul 19, 2024 | Barclays | Underweight | Underweight | Hold |
| Jul 10, 2024 | Citigroup | Neutral | Neutral | Hold |
| Jun 24, 2024 | Wells Fargo | Hold | Hold | Hold |
| Jun 24, 2024 | Exane BNP Paribas | - | Underperform | Initialise |
| May 02, 2024 | Wells Fargo | Underweight | Underweight | Hold |
| Apr 16, 2024 | UBS | Equal-Weight | Equal-Weight | Hold |
| Apr 02, 2024 | Citigroup | Buy | Neutral | Downgrade |
Clorox Company's last stock rating was published by Citigroup on Aug 28, 2024. The company gave CLX a "Neutral" rating, the same as its previous rate.
Clorox Company Financial Forecast
Clorox Company Revenue Forecast
| Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.99B | $1.39B | $2.02B | $1.92B | $1.72B | $1.74B | - | $1.81B | $1.69B | $1.81B | $1.80B | $1.78B | $1.84B | $1.92B | $1.98B | $1.78B |
| Avg Forecast | $2.07B | $1.93B | $1.78B | $1.70B | $1.99B | $1.85B | $1.71B | $1.66B | $1.92B | $1.80B | $1.65B | $1.65B | $1.95B | $1.87B | $1.80B | $1.31B | $1.88B | $1.82B | $1.66B | $1.69B | $1.86B | $1.79B | $1.67B | $1.70B | $1.91B | $1.86B | $1.75B | $1.75B | $1.87B | $1.71B |
| High Forecast | $2.15B | $2.00B | $1.85B | $1.77B | $2.06B | $1.92B | $1.78B | $1.72B | $2.00B | $1.86B | $1.72B | $1.67B | $2.02B | $1.94B | $1.82B | $1.37B | $1.95B | $1.89B | $1.72B | $1.76B | $1.86B | $1.87B | $1.74B | $1.77B | $1.99B | $1.94B | $1.82B | $1.83B | $1.95B | $1.78B |
| Low Forecast | $1.98B | $1.84B | $1.71B | $1.63B | $1.90B | $1.77B | $1.64B | $1.59B | $1.84B | $1.72B | $1.58B | $1.63B | $1.86B | $1.79B | $1.77B | $1.27B | $1.79B | $1.74B | $1.59B | $1.62B | $1.86B | $1.74B | $1.62B | $1.65B | $1.85B | $1.81B | $1.70B | $1.70B | $1.82B | $1.66B |
| # Analysts | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 12 | 6 | 3 | 3 | 6 | 9 | 6 | 4 | 3 | 7 | 5 | 3 | 4 | 8 | 5 | 10 | 10 | 10 | 10 | 10 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.10% | 1.06% | 1.08% | 1.05% | 1.03% | 1.03% | - | 1.01% | 1.01% | 1.06% | 0.95% | 0.96% | 1.05% | 1.09% | 1.06% | 1.04% |
Clorox Company's average Quarter revenue forecast for Mar 24 based on 3 analysts is $1.87B, with a low forecast of $1.79B, and a high forecast of $1.94B. CLX's average Quarter revenue forecast represents a -6.04% decrease compared to the company's last Quarter revenue of $1.99B (Dec 23).
Clorox Company EBITDA Forecast
| Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 12 | 6 | 3 | 3 | 6 | 9 | 6 | 4 | 3 | 7 | 5 | 3 | 4 | 8 | 5 | 10 | 10 | 10 | 10 | 10 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $390.00M | $227.00M | $258.00M | $224.00M | $153.00M | $194.00M | - | $278.00M | $168.00M | $264.00M | $177.00M | $17.00M | $407.00M | $600.00M | $467.00M | $366.00M |
| Avg Forecast | $306.68M | $284.98M | $263.70M | $251.75M | $293.65M | $273.48M | $253.23M | $245.47M | $284.57M | $265.55M | $244.44M | $243.66M | $288.08M | $216.90M | $266.72M | $193.20M | $277.32M | $197.18M | $245.28M | $232.90M | $282.45M | $179.26M | $204.00M | $211.72M | $223.65M | $15.39M | $349.84M | $367.24M | $368.44M | $317.78M |
| High Forecast | $318.21M | $295.69M | $273.62M | $261.22M | $304.69M | $283.77M | $262.75M | $254.70M | $295.27M | $275.54M | $253.64M | $246.65M | $298.92M | $260.28M | $269.72M | $202.56M | $287.74M | $236.62M | $254.50M | $279.47M | $282.45M | $215.11M | $244.80M | $254.07M | $268.38M | $18.47M | $419.80M | $440.69M | $442.12M | $381.34M |
| Low Forecast | $293.26M | $272.51M | $252.17M | $240.74M | $280.80M | $261.52M | $242.15M | $234.73M | $272.12M | $253.94M | $233.75M | $240.67M | $275.48M | $173.52M | $262.23M | $187.70M | $265.19M | $157.75M | $234.55M | $186.32M | $282.45M | $143.41M | $163.20M | $169.38M | $178.92M | $12.31M | $279.87M | $293.79M | $294.75M | $254.23M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.46% | 1.17% | 0.93% | 1.14% | 0.62% | 0.83% | - | 1.55% | 0.82% | 1.25% | 0.79% | 1.10% | 1.16% | 1.63% | 1.27% | 1.15% |
3 analysts predict CLX's average Quarter EBITDA for Mar 24 to be $216.90M, with a high of $260.28M and a low of $173.52M. This is -44.38% lower than Clorox Company's previous annual EBITDA (Dec 23) of $390.00M.
Clorox Company Net Income Forecast
| Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 12 | 6 | 3 | 3 | 6 | 9 | 6 | 4 | 3 | 7 | 5 | 3 | 4 | 8 | 5 | 10 | 10 | 10 | 10 | 10 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $93.00M | $22.00M | $176.00M | $-209.00M | $99.00M | $85.00M | - | $150.00M | $72.00M | $142.00M | $97.00M | $-61.00M | $259.00M | $415.00M | $310.00M | $241.00M |
| Avg Forecast | $274.02M | $237.75M | $222.83M | $219.04M | $269.99M | $228.84M | $200.78M | $185.13M | $252.00M | $211.93M | $188.61M | $174.60M | $194.38M | $117.88M | $136.64M | $-30.34M | $146.00M | $107.16M | $82.39M | $125.27M | $115.22M | $97.42M | $83.79M | $113.88M | $122.57M | $-55.23M | $222.62M | $254.01M | $244.57M | $209.25M |
| High Forecast | $287.41M | $249.37M | $233.72M | $229.75M | $283.19M | $240.03M | $210.59M | $194.17M | $264.32M | $222.29M | $245.80M | $197.88M | $203.88M | $141.46M | $155.62M | $-4.14M | $153.14M | $128.60M | $86.42M | $150.32M | $115.22M | $116.91M | $100.54M | $136.66M | $147.08M | $-44.18M | $267.15M | $304.81M | $293.49M | $251.10M |
| Low Forecast | $258.44M | $224.23M | $210.16M | $206.58M | $254.64M | $215.83M | $189.36M | $174.60M | $237.67M | $199.88M | $147.23M | $165.54M | $183.33M | $94.31M | $122.73M | $-55.16M | $137.70M | $85.73M | $77.70M | $100.22M | $115.22M | $77.94M | $67.03M | $91.10M | $98.05M | $-66.28M | $178.10M | $203.21M | $195.66M | $167.40M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.68% | -0.73% | 1.21% | -1.95% | 1.20% | 0.68% | - | 1.54% | 0.86% | 1.25% | 0.79% | 1.10% | 1.16% | 1.63% | 1.27% | 1.15% |
Clorox Company's average Quarter net income forecast for Mar 24 is $117.88M, with a range of $94.31M to $141.46M. CLX's average Quarter net income forecast represents a 26.75% increase compared to the company's last Quarter net income of $93.00M (Dec 23).
Clorox Company SG&A Forecast
| Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 12 | 6 | 3 | 3 | 6 | 9 | 6 | 4 | 3 | 7 | 5 | 3 | 4 | 8 | 5 | 10 | 10 | 10 | 10 | 10 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $508.00M | $276.00M | $540.00M | $517.00M | $438.00M | $422.00M | - | $386.00M | $408.00M | $418.00M | $484.00M | $437.00M | $456.00M | $417.00M | $493.00M | $453.00M |
| Avg Forecast | $523.60M | $486.56M | $450.23M | $429.83M | $501.36M | $466.93M | $432.35M | $419.10M | $485.85M | $453.39M | $417.35M | $416.02M | $491.86M | $303.35M | $455.39M | $329.86M | $473.47M | $275.77M | $418.78M | $368.75M | $454.53M | $250.70M | $495.43M | $335.23M | $611.57M | $395.66M | $391.96M | $255.23M | $388.95M | $393.32M |
| High Forecast | $543.29M | $504.85M | $467.16M | $445.99M | $520.21M | $484.49M | $448.61M | $434.86M | $504.12M | $470.44M | $433.04M | $421.12M | $510.35M | $364.02M | $460.51M | $345.83M | $491.28M | $330.93M | $434.52M | $442.50M | $454.53M | $300.84M | $594.51M | $402.27M | $733.88M | $474.79M | $470.35M | $306.28M | $466.74M | $471.99M |
| Low Forecast | $500.70M | $465.27M | $430.54M | $411.03M | $479.43M | $446.51M | $413.44M | $400.76M | $464.60M | $433.56M | $399.09M | $410.91M | $470.34M | $242.68M | $447.72M | $320.47M | $452.76M | $220.62M | $400.46M | $295.00M | $454.53M | $200.56M | $396.34M | $268.18M | $489.25M | $316.53M | $313.56M | $204.19M | $311.16M | $314.66M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.12% | 0.84% | 1.14% | 1.87% | 1.05% | 1.14% | - | 1.54% | 0.82% | 1.25% | 0.79% | 1.10% | 1.16% | 1.63% | 1.27% | 1.15% |
Clorox Company's average Quarter SG&A projection for Mar 24 is $303.35M, based on 3 Wall Street analysts, with a range of $242.68M to $364.02M. The forecast indicates a -40.29% fall compared to CLX last annual SG&A of $508.00M (Dec 23).
Clorox Company EPS Forecast
| Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 12 | 6 | 3 | 3 | 6 | 9 | 6 | 4 | 3 | 7 | 5 | 3 | 4 | 8 | 5 | 10 | 10 | 10 | 10 | 10 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.75 | $0.18 | $1.43 | $-1.69 | $0.81 | $0.69 | - | $1.22 | $0.59 | $1.15 | $0.79 | $-0.49 | $2.06 | $3.28 | $2.45 | $1.92 |
| Avg Forecast | $2.19 | $1.90 | $1.78 | $1.75 | $2.16 | $1.83 | $1.61 | $1.48 | $2.02 | $1.69 | $1.51 | $1.40 | $1.55 | $1.36 | $1.09 | $-0.24 | $1.17 | $1.23 | $0.66 | $0.74 | $0.93 | $0.92 | $0.79 | $1.03 | $1.32 | $1.48 | $1.78 | $2.32 | $1.99 | $1.67 |
| High Forecast | $2.30 | $1.99 | $1.87 | $1.84 | $2.26 | $1.92 | $1.68 | $1.55 | $2.11 | $1.78 | $1.97 | $1.58 | $1.63 | $1.43 | $1.24 | $-0.03 | $1.22 | $1.29 | $0.69 | $0.78 | $0.93 | $0.97 | $0.84 | $1.09 | $1.39 | $1.56 | $1.88 | $2.44 | $2.10 | $1.76 |
| Low Forecast | $2.07 | $1.79 | $1.68 | $1.65 | $2.04 | $1.73 | $1.51 | $1.40 | $1.90 | $1.60 | $1.18 | $1.32 | $1.47 | $1.28 | $0.98 | $-0.44 | $1.10 | $1.16 | $0.62 | $0.70 | $0.93 | $0.89 | $0.77 | $0.99 | $1.27 | $1.42 | $1.72 | $2.23 | $1.92 | $1.61 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.69% | -0.74% | 1.22% | -1.38% | 1.23% | 0.93% | - | 1.32% | 0.74% | 1.11% | 0.60% | -0.33% | 1.16% | 1.42% | 1.23% | 1.15% |
According to 3 Wall Street analysts, Clorox Company's projected average Quarter EPS for Mar 24 is $1.36, with a low estimate of $1.28 and a high estimate of $1.43. This represents a 81.53% increase compared to CLX previous annual EPS of $0.75 (Dec 23).
Clorox Company Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| EL | Estée Lauder Companies | $84.56 | $176.72 | 108.99% | Hold |
| CHD | Church & Dwight | $104.04 | $111.00 | 6.69% | Buy |
| KMB | Kimberly-Clark | $143.52 | $144.15 | 0.44% | Hold |
| UL | Unilever | $65.06 | $59.00 | -9.31% | Buy |
| PG | Procter & Gamble Company | $174.08 | $156.05 | -10.36% | Buy |
| CLX | Clorox Company | $166.27 | $146.67 | -11.79% | Hold |
| CL | Colgate-Palmolive Company | $105.73 | $90.75 | -14.17% | Buy |
CLX Forecast FAQ
Is Clorox Company a good buy?
No, according to 20 Wall Street analysts, Clorox Company (CLX) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 35.00% of CLX's total ratings.
What is CLX's price target?
Clorox Company (CLX) average price target is $146.67 with a range of $122 to $185, implying a -11.79% from its last price of $166.27. The data is based on 20 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Clorox Company stock go up soon?
According to Wall Street analysts' prediction for CLX stock, the company can go down by -11.79% (from the last price of $166.27 to the average price target of $146.67), up by 11.26% based on the highest stock price target, and down by -26.63% based on the lowest stock price target.
Can Clorox Company stock reach $200?
CLX's average twelve months analyst stock price target of $146.67 does not support the claim that Clorox Company can reach $200 in the near future.
What are Clorox Company's analysts' financial forecasts?
Clorox Company's analysts financial forecasts for the fiscal year (Jun 2026) are as follows: average revenue is $7.21B (high $7.48B, low $6.89B), average EBITDA is $1.07B (high $1.11B, low $1.02B), average net income is $884.74M (high $927.99M, low $834.43M), average SG&A $1.82B (high $1.89B, low $1.74B), and average EPS is $7.07 (high $7.42, low $6.67). CLX's analysts financial forecasts for the fiscal year (Jun 2027) are as follows: average revenue is $7.49B (high $7.77B, low $7.16B), average EBITDA is $1.11B (high $1.15B, low $1.06B), average net income is $953.64M (high $1B, low $899.41M), average SG&A $1.89B (high $1.96B, low $1.81B), and average EPS is $7.63 (high $8, low $7.19).
Did the CLX's actual financial results beat the analysts' financial forecasts?
Based on Clorox Company's last annual report (Jun 2023), the company's revenue was $7.39B, which missed the average analysts forecast of $8.91B by -17.09%. Apple's EBITDA was $773M, missing the average prediction of $1.24B by -37.41%. The company's net income was $149M, missing the average estimation of $576.05M by -74.13%. Apple's SG&A was $1.92B, missing the average forecast of $1.99B by -3.73%. Lastly, the company's EPS was $1.21, missing the average prediction of $4.72 by -74.38%. In terms of the last quarterly report (Dec 2023), Clorox Company's revenue was $1.99B, beating the average analysts' forecast of $1.8B by 10.30%. The company's EBITDA was $390M, beating the average prediction of $266.72M by 46.22%. Clorox Company's net income was $93M, missing the average estimation of $136.64M by -31.94%. The company's SG&A was $508M, beating the average forecast of $455.39M by 11.55%. Lastly, the company's EPS was $0.75, missing the average prediction of $1.09 by -31.36%